Delivery Order SPE2DB22D3501-SPE2DB24FVQ20

Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $2.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 20 mg capsules. The $17,626.91 firm fixed-price contract has a completion date of June 1, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 20 mg capsules. The contract has a ceiling value of $1,733.64 and a completion date of May 7, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award, valued at $2,283.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 10 mg capsules. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as Amerisourcebergen, with a ceiling value of up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Carvedilol ER 10 mg capsules, a cardiovascular medication, with an ultimate completion date of June 4, 2024 and a ceiling value of $40,853.73. This award is a Delivery Order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 20 mg capsules. The contract, valued at $1,203.76, is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 80 mg capsules. The firm-fixed-price delivery order, valued at $14,648.38, is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical and...
This federal contract award, valued at $1,322.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 10 mg capsules, a cardiovascular medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of November 21, 2024. This award is associated with a larger Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the provision of Carvedilol ER 40 mg capsules to the U.S. government. The contract, valued at $16,506.45, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,617.82 firm fixed-price delivery order is for the supply of Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 20 mg capsules. The contract has a ceiling value of $101,341.94 and runs through September 9, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation. Amerisourcebergen is the prime contractor for this award, which is associated with a larger...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVQ20
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 10 mg capsules. The contract has a ceiling value of $2,451.79 and an ultimate completion date of May 10, 2024. This contract is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC has a maximum value of $999,999,999.00 and runs through November 2026, enabling the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. This delivery order and the broader IDC demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of the Department of Defense and other government agencies.

Generated 5/16/25, 12:16 PM